The First Hospital of Changsha, Changsha, 410005, China.
The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, 410008, China.
BMC Urol. 2024 Apr 20;24(1):91. doi: 10.1186/s12894-024-01474-z.
Sleep quality may be related to benign prostatic hyperplasia (BPH), however causal associations have not been established. This study aimed to evaluate causal relationships between six sleep traits ([i] day time napping, [ii] daytime sleepiness, [iii] insomnia, [iv] long sleep duration, [v] short sleep duration, and [vi] sleep duration per hour) and BPH through a bidirectional Mendelian randomization (MR) study.
Genome-wide association summary statistics of sleep traits and BPH were downloaded from public databases. Inverse variance weighting (IVW) was used as the main approach for causal inference. For causal estimates identified by IVW, various sensitivity analyses were performed to assess the reliability of the results: (i) four additional MR methods to complement IVW; (ii) Cochran's Q test to assess heterogeneity; (iii) MR-Egger intercept test and MR-PRESSO global test to assess horizontal pleiotropy; and (iv) leave-one-out method to assess stability.
Forward MR analyses indicated that genetically predicted insomnia symptom significantly increased BPH risk (OR = 1.267, 95% CI: 1.003-1.601, P = 0.048), while reverse MR analyses identified that genetically predicted liability to BPH significantly increased the incidence of insomnia (OR = 1.026, 95% CI: 1.000-1.052, P = 0.048). In a replicate MR analysis based on summary statistics including exclusively male participants, the finding of increased risk of BPH due to genetically predicted insomnia symptom was further validated (OR = 1.488, 95% CI: 1.096-2.022, P = 0.011). No further causal links were identified. In addition, sensitivity tests demonstrated the reliability of the MR results.
This study identified that a higher prevalence of genetically predicted insomnia symptoms may significantly increase the risk of BPH, while genetically predicted liability to BPH may in turn increase the incidence of insomnia symptom. Therefore, improving sleep quality and reducing the risk of insomnia could be a crucial approach for the prevention of BPH.
睡眠质量可能与良性前列腺增生(BPH)有关,但因果关系尚未建立。本研究旨在通过双向孟德尔随机化(MR)研究评估六种睡眠特征([i]白天小睡,[ii]白天嗜睡,[iii]失眠,[iv]长睡眠时间,[v]短睡眠时间和[vi]每小时睡眠时间)与 BPH 之间的因果关系。
从公共数据库下载睡眠特征和 BPH 的全基因组关联汇总统计数据。反向方差加权(IVW)被用作因果推理的主要方法。对于 IVW 确定的因果估计,进行了各种敏感性分析以评估结果的可靠性:(i)四种额外的 MR 方法来补充 IVW;(ii)Cochran's Q 检验评估异质性;(iii)MR-Egger 截距检验和 MR-PRESSO 全局检验评估水平偏倚;(iv)逐一剔除法评估稳定性。
正向 MR 分析表明,遗传预测的失眠症状显著增加了 BPH 风险(OR=1.267,95%CI:1.003-1.601,P=0.048),而反向 MR 分析表明,遗传预测的 BPH 易感性显著增加了失眠的发生率(OR=1.026,95%CI:1.000-1.052,P=0.048)。在基于仅包括男性参与者的汇总统计数据的重复 MR 分析中,由于遗传预测的失眠症状而导致的 BPH 风险增加的发现得到了进一步验证(OR=1.488,95%CI:1.096-2.022,P=0.011)。没有发现其他因果关系。此外,敏感性测试证明了 MR 结果的可靠性。
本研究表明,遗传预测的失眠症状发生率较高可能显著增加 BPH 的风险,而遗传预测的 BPH 易感性可能反过来增加失眠症状的发生率。因此,改善睡眠质量和降低失眠风险可能是预防 BPH 的关键方法。